YOLFTbeta
Abnova Taiwan Corp

Abnova Taiwan Corp

4133 · TW · Healthcare / Biotechnology

19.85TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close19.85
Open19.85
Day Range19.75 – 20.05
52-Week Range20.00 – 29.15
Volume50.93K
Market Cap1.24B
P/E (TTM)27.64
Forward P/E25.71
EPS0.74
Dividend Yield0.55%
Beta0.29
50-Day Avg20.72
200-Day Avg22.20

About

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company's products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company provides integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production and scale up; assay development services; circulating tumor cell and DNA; germline genetic DNA; and FFPE tumor tissue DNA services. It serves academic, research institutions, and pharmaceutical factories. Abnova (Taiwan) Corporation was founded in 2002 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOPeiru Ji
  • Employees0
  • HeadquartersNo. 108, Jhouzih Street, Taipei, Taiwan, 114, Taiwan
  • Websitehttps://www.abnova.com

Leadership

  • Peiru JiGM & Director
  • Yaping ZhangAccounting Supervisor
  • Yi Huang HuangDeputy General Manager

Financials

Income Statement

Currency: TWD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue270.29M402.83M475.07M472.57M463.77M463.70M438.11M451.37M439.83M475.07M426.02M414.16M456.45M451.49M411.76M382.05M355.26M351.30M
Growth (%)-+49.04%+17.93%-0.53%-1.86%-0.02%-5.52%+3.03%-2.56%+8.01%-10.32%-2.79%+10.21%-1.09%-8.80%-7.21%-7.01%-1.11%
Cost of Revenue8.77M172.01M193.41M204.03M209.55M227.51M214.36M237.66M233.17M246.21M240.64M228.81M242.95M254.15M210.33M208.14M192.00M211.43M
Gross Profit-230.82M281.67M268.54M254.23M236.19M223.75M213.71M206.66M228.87M185.38M185.35M213.50M197.34M201.43M173.91M163.26M139.87M
Gross Margin-57.30%59.29%56.83%54.82%50.94%51.07%47.35%46.99%48.18%43.51%44.75%46.77%43.71%48.92%45.52%45.96%39.81%
Operating Expense-137.56M149.68M148.28M162.80M156.92M161.28M162.63M158.14M169.88M163.75M156.77M160.31M159.60M105.62M126.72M128.99M122.82M
Operating Income46.44M93.27M131.99M120.26M91.42M79.27M62.48M51.07M48.52M58.99M21.63M28.58M53.19M37.74M95.81M47.19M34.27M17.05M
Operating Margin17.18%23.15%27.78%25.45%19.71%17.09%14.26%11.32%11.03%12.42%5.08%6.90%11.65%8.36%23.27%12.35%9.65%4.85%
EBITDA-162.49M188.38M175.63M134.49M118.59M81.36M87.26M84.31M108.26M78.53M75.41M97.26M79.79M129.60M81.21M103.47M45.66M
EBITDA Margin-40.34%39.65%37.17%29.00%25.58%18.57%19.33%19.17%22.79%18.43%18.21%21.31%17.67%31.48%21.26%29.13%13.00%
Net Income39.14M99.56M149.04M119.86M76.84M72.90M65.64M44.91M53.54M58.97M46.12M3.26M36.53M28.37M74.84M43.68M61.61M-1.14M
Net Income Margin14.48%24.71%31.37%25.36%16.57%15.72%14.98%9.95%12.17%12.41%10.83%0.79%8.00%6.28%18.18%11.43%17.34%-0.32%
R&D50.17M27.95M30.64M28.86M38.56M40.67M42.74M48.86M48.55M52.70M56.62M54.73M50.96M53.14M48.74M38.40M40.02M45.56M
R&D as % of Total Revenue18.56%6.94%6.45%6.11%8.31%8.77%9.76%10.82%11.04%11.09%13.29%13.22%11.16%11.77%11.84%10.05%11.27%12.97%
Interest Expense0924.00K185.00K14.00K0000029.00K0364.00K275.00K246.00K152.00K142.00K118.00K424.00K
Interest Expense % of Total Revenue0.00%0.23%0.04%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.09%0.06%0.05%0.04%0.04%0.03%0.12%

Balance Sheet

Currency: TWD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets857.02M1.31B1.33B1.36B1.29B1.29B1.31B1.25B1.25B1.30B1.29B1.26B1.29B1.28B1.37B1.36B1.40B1.33B
Total Liabilities112.71M95.34M64.24M84.51M63.12M55.42M78.15M82.35M72.06M79.05M67.77M71.59M83.49M71.29M82.83M69.42M91.65M70.74M
Total Equity744.31M1.21B1.27B1.27B1.23B1.23B1.23B1.17B1.18B1.22B1.23B1.19B1.21B1.21B1.29B1.29B1.31B1.26B
Cash204.71M598.63M589.31M571.36M487.77M491.74M503.01M102.52M162.65M187.56M145.01M167.24M257.76M306.72M367.06M423.51M448.55M377.83M
Total Debt-34.80M1.44M1.30M882.00K286.00K191.00K1.48M1.08M736.00K354.00K17.70M16.06M8.18M10.88M7.71M24.01M18.50M
Net Debt--563.83M-587.87M-570.06M-486.88M-491.46M-502.82M-101.04M-161.57M-186.83M-144.66M-149.54M-241.70M-298.55M-356.18M-415.81M-424.54M-359.33M

Cash Flow

Currency: TWD2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-63.72M114.40M134.22M76.02M109.78M94.18M73.43M71.94M67.53M89.17M74.51M105.30M92.88M132.37M76.22M50.85M-4.19M
Investing Cash Flow--21.77M-4.41M-33.08M-40.52M-34.35M-17.41M-366.39M30.62M-18.32M-82.97M-3.81M-1.13M960.00K-13.37M36.79M19.78M-6.22M
Financing Cash Flow882.00K351.97M-119.32M-119.09M-119.09M-71.46M-65.50M-107.96M-39.01M-23.52M-48.44M-46.73M-14.17M-43.80M-61.40M-55.62M-49.09M-60.01M
Capital Expenditure54.17M15.01M17.73M29.84M40.26M34.11M19.66M168.29M78.28M87.98M84.32M13.30M7.74M834.00K13.86M28.89M7.72M3.54M
Free Cash Flow-48.71M96.67M104.38M35.76M75.67M74.52M-94.86M-6.34M-20.45M4.85M61.22M97.56M92.04M118.51M47.33M43.13M-7.73M
Dividends Paid--89.32M119.09M119.09M71.46M65.50M59.55M11.14M23.52M48.44M36.33M6.05M36.33M27.86M48.44M43.60M54.50M
FCF to OCF-76.45%84.50%77.77%47.04%68.93%79.12%-129.19%-8.82%-30.28%5.44%82.16%92.65%99.10%89.53%62.10%84.82%184.49%
Dividend Paid to FCF--92.39%114.10%333.02%94.43%87.90%-62.77%-175.73%-115.00%999.44%59.35%6.21%39.47%23.50%102.35%101.07%-704.65%

Earnings

Report DateJun 30, 2009Sep 30, 2009Dec 31, 2009Jun 2, 2010Sep 1, 2010Dec 1, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 30, 2012Oct 29, 2012Mar 29, 2013May 14, 2013Aug 14, 2013Nov 13, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Nov 13, 2015Mar 31, 2016May 14, 2016Aug 13, 2016Nov 15, 2016Mar 30, 2017May 12, 2017Aug 12, 2017Nov 10, 2017Mar 31, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Mar 28, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Mar 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Jun 2, 2021Sep 1, 2021Dec 1, 2021Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 30, 2023May 31, 2023Aug 2, 2023
EPS Estimate--------------------------------0.270.28--------------------
EPS Actual1.021.360.400.680.740.660.630.370.460.470.440.240.290.260.400.320.250.200.220.200.260.370.010.410.140.170.240.220.140.290.200.280.280.220.140.210.160.25-0.030.040.010.030.130.070.250.160.110.220.290.310.440.200.180.20
Surprise--------------------------------3.70%-21.43%--------------------
Timing-----------After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-------After-hoursPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-market--------------------

Key Statistics & Ratios

Market Cap1.24B
Enterprise Value856.17M
Trailing P/E27.64
Forward P/E25.71
PEG Ratio0.00
Price / Sales3.58
Price / Book0.98
EPS0.74
Book Value21.03
Revenue (TTM)345.45M
Gross Profit (TTM)167.73M
EBITDA38.06M
Profit Margin12.99%
Operating Margin8.06%
Return on Equity3.58%
Return on Assets1.00%
Shares Outstanding60.55M
Shares Float47.32M
Beta0.29
Dividend Yield0.55%
Dividend Rate0.11
Payout Ratio15.14%

Dividends

20231×
0.80Jun 15, 2023
20221×
0.46Jun 16, 2022
20211×
0.60Jul 22, 2021
20201×
0.10Jul 16, 2020
20191×
0.60Jul 11, 2019
20181×
0.80Jul 5, 2018
20171×
0.40Aug 28, 2017
20161×
0.19Aug 26, 2016
20151×
0.98Jul 8, 2015
20141×
1.05Jul 17, 2014
20131×
1.15Jul 4, 2013
20121×
1.92Jul 3, 2012
20111×
1.92Jul 15, 2011
20101×
1.44Jul 8, 2010

Stock Splits

  • Aug 28, 2017103:100
  • Aug 26, 2016633:625